Lamotrigine Tablet
Product Images NDC 82804-068

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 82804-068). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (2d955155 686d 40cd 898e Df7d760247a5 740 1)

FDA Label Image

Image (2d955155 686d 40cd 898e Df7d760247a5 789 2)

Image (2d955155 686d 40cd 898e Df7d760247a5 789 2)
This image displays four types of Lamotrigine oral tablets by strength and color. The 25 mg white tablet is oblong with "U U 111" imprint; the 100 mg white tablet is triangular with "U U 112" imprint; the 150 mg white tablet is triangular with "U U 113" imprint; and the 200 mg light blue tablet is triangular with "U U 114" imprint.*
FDA Label Image

Image (2d955155 686d 40cd 898e Df7d760247a5 789 3)

FDA Label Image

Molecular Structure (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01)

Molecular Structure (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01)
Chemical structure diagram of Lamotrigine, showing a triazine ring with two amino groups and a dichlorophenyl group attached, as depicted in the image.*
FDA Label Image

Figure 1 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02)

Figure 1 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02)
A Kaplan-Meier survival curve chart showing failure probability (%) over a period of up to 100 weeks. The chart compares two groups labeled Lamotrigine and Placebo, with censored data points indicated. The y-axis represents failure probability percentage, and the x-axis represents time in weeks.*
FDA Label Image

Figure 2 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03)

Figure 2 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03)
A Kaplan-Meier failure probability curve comparing Lamotrigine and Placebo over 80 weeks. The y-axis shows failure probability percentage from 0 to 100%, and the x-axis shows time in weeks. The graph includes censored data indicated by marks on the curves for both treatment groups.*
FDA Label Image

82804-068-30 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 07)

82804-068-30 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 07)
Lamotrigine 200 mg tablet label for oral use, distributed by Proficient Rx LP. The label states 30 tablets per container and specifies each scored tablet contains 200 mg of lamotrigine, USP. It includes product ID ZL006830 and manufacturer information for Unichem Laboratories Ltd in Goa, India. The label features barcodes, a QR code, and storage instructions at 20°-25°C (68°-77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.